The use of neostigmine to treat postoperative ileus in orthopedic spinal patients.

Abstract

Ileus is a common complication of spinal surgery, affecting 5% to 12% of all patients. Often this ileus is secondary to acute colonic pseudo-obstruction. This study is a prospective clinical trial of neostigmine in seven spinal patients with ileus after surgery to demonstrate its efficacy. All patients had evidence of the Ogilvie syndrome that was unresponsive to 24 hours of conservative therapy. Patients received 2 mg neostigmine, and abdominal circumference, clinical response, and radiographic colonic measurements were recorded. Patients were followed for recurrence of ileus for their remaining time in the hospital. Six patients had prompt colonic decompression, and no patient had recurrence of colonic distension. Side effects were minimal. These results suggest that postoperative spinal patients with ileus secondary to acute colonic pseudo-obstruction that is unresponsive to conservative therapy benefit from treatment with neostigmine, resulting in safe, rapid decompression of the colon.

• Authors: P L Althausen, M C Gupta, D R Benson, D A Jones
• Journal: Journal of spinal disorders (J Spinal Disord) Vol. 14 Issue 6 Pg. 541-5 (Dec 2001) ISSN: 0895-0385 [Print] United States
• PMID: 11723407 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Neostigmine

Topics

• Adolescent
• Adult
• Female
• Humans
• Intestinal Obstruction (drug therapy, etiology)
• Male
• Middle Aged
• Neostigmine (adverse effects, therapeutic use)
• Orthopedic Procedures (adverse effects)
• Prospective Studies
• Radiography
• Spinal Diseases (surgery)
• Spine (diagnostic imaging, surgery)
• Treatment Outcome